Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma.

Abstract

This EORTC multicentre study analysed the efficacy and tolerability in patients with metastatic uveal melanoma of BOLD chemotherapy in combination with recombinant interferon alpha-2b. The dose of bleomycin was 15 mg on days 2 and 5, of vincristine 1 mg/m(2) on days 1 and 4, of lomustine 80 mg on day 1, and of dacarbazine (DTIC) 200 mg/m(2) on days 1-5… (More)

Topics

Cite this paper

@article{Kivel2003BleomycinVL, title={Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma.}, author={Tero T Kivel{\"a} and Silviu Cristian Suciu and J. Hansson and W. H. J. Kruit and M Vuoristo and Otto Kloke and Michael A. Gore and Marjo H Hahka-Kemppinen and L M Parvinen and Elina Kumpulainen and Yves Humblet and Seppo Olavi Pyrh{\"o}nen}, journal={European journal of cancer}, year={2003}, volume={39 8}, pages={1115-20} }